|
Gene ID
|
Control %
|
Patient %
|
Difference
|
P value
|
Q value
|
|---|
|
LOC339166
|
76
|
34
|
− 42
|
3.94 × 10–12
|
1.67 × 10–9
|
|
LOC339166
|
74
|
32
|
− 40
|
1.96 × 10–11
|
7.97 × 10–9
|
|
LOC339166
|
75
|
35
|
− 39
|
9.19 × 10–11
|
3.63 × 10–8
|
|
LOC339166
|
71
|
35
|
− 35
|
4.71 × 10–9
|
1.70 × 10–6
|
|
LOC339166
|
75
|
39
|
− 35
|
8.62 × 10–9
|
3.05 × 10–6
|
|
FANK1
|
19
|
48
|
+ 28
|
2.31 × 10–12
|
9.82 × 10–10
|
|
CILP2
|
30
|
51
|
+ 23
|
1.94 × 10–4
|
3.40 × 10–2
|
|
A2M-AS1
|
13
|
32
|
+ 21
|
4.93 × 10–5
|
1.05 × 10–2
|
|
SPIN2B
|
20
|
40
|
+ 20
|
2.45 × 10–5
|
5.58 × 10–3
|
|
MT1M
|
12
|
29
|
+ 18
|
1.21 × 10–4
|
2.29 × 10–2
|
- For each Gene ID, there is the corresponding average percentage methylation for the control subjects and ME/CFS patients, with the differences shown (− is hypo-methylated, + is hyper-methylated). P and Q values are indicated. The full dataset is available in Additional file 1: Excel file ‘MethylKit_Promoter_Full’
